CVE-2026-0229PAN-OS: Denial of Service in Advanced DNS Security Feature
Updated under an hour ago ()
Does this affect you?
It affects Palo Alto Networks Cloud NGFW and 2 other products. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A denial-of-service (DoS) vulnerability in the Advanced DNS Security (ADNS) feature of Palo Alto Networks PAN-OS® software enables an unauthenticated attacker to initiate system reboots using a maliciously crafted packet. Repeated attempts to initiate a reboot causes the firewall to enter maintenance mode. Cloud NGFW and Prisma Access® are not impacted by this vulnerability.
- CVSS
- 6.6 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:U/AU:Y/R:U/V:D/RE:M/U:Amber
- Weakness (CWE)
- CWE-754
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- palo_alto
- NVD analysis
- Deferred
- Record last updated
- Feb 11, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Palo Alto Networks Cloud NGFW palo_alto_networks:cloud_ngfw (from the name) | all versions not affected | CNA record |
Palo Alto Networks PAN-OS palo_alto_networks:pan-os | from 12.1.0 before 12.1.4; fixed at 12.1.4; from 11.2.0 before 11.2.10; fixed at 11.2.10; from 11.1.0 before 11.1.11 not affected; fixed at 11.1.11; from 10.2.0 before 10.2.17 not affected; fixed at 10.2.17 | CNA record |
Palo Alto Networks Prisma Access palo_alto_networks:prisma_access (from the name) | from All before 10.2.10-h28 not affected; fixed at 11.2.7-h10, fixed at 10.2.10-h28 | CNA record |
References
- https://security.paloaltonetworks.com/CVE-2026-0229vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.